Does Precise Tumor include clinical trial matching?

Does Precise Tumor include clinical trial matching?

• A. No
• B. Yes
• C. Only for select cancers
• D. Not specified

Answer: (B)

Clinical trial matching is a key feature of precision oncology. By using the tumor’s molecular profile, histology, stage, prior treatments, and patient factors, a program can search current trials and determine which ones align with a patient’s situation. A platform like Precise Tumor typically integrates up‑to‑date trial databases with genetic findings to surface eligible trials, locations, and enrollment criteria, helping clinicians and patients consider experimental therapies that target specific alterations or cancer subtypes. Because that capability is widely expected in comprehensive precision oncology offerings, it is included. It’s worth noting that eligibility and availability vary by region and time, so matches can change, but the mechanism and goal are to enable clinical trial access through matching.

Clinical trial matching is a key feature of precision oncology. By using the tumor’s molecular profile, histology, stage, prior treatments, and patient factors, a program can search current trials and determine which ones align with a patient’s situation. A platform like Precise Tumor typically integrates up‑to‑date trial databases with genetic findings to surface eligible trials, locations, and enrollment criteria, helping clinicians and patients consider experimental therapies that target specific alterations or cancer subtypes. Because that capability is widely expected in comprehensive precision oncology offerings, it is included. It’s worth noting that eligibility and availability vary by region and time, so matches can change, but the mechanism and goal are to enable clinical trial access through matching.